Medication info
Eden Memantine Tablet 20 mg (Memantine Hydrochloride)

Eden Memantine Tablet 20 mg (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›20mg / 1 tablet
Manufacturer / importer
Eden Pharma Co., Ltd.
Appearance
Pink oval film-coated tablets
Packaging
Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle
Approval status
Active

MFDS item code 202500258 · Approved 2025.02.07 · Insurance code 628902460

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
Treatment must be initiated by a physician experienced in the diagnosis and treatment of Alzheimer’s dementia, and only if a caregiver can regularly check that the patient is taking the medication. The diagnosis should be made according to currently accepted guidelines. The clinical benefit of this medication and the patient’s tolerability of treatment should be regularly reassessed. This medication is administered orally once daily, at the same time each day. If necessary, it may be administered twice daily. It may be taken with or without food. 1. Adults Dose titration: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (Days 1–7): Administer 5mg once daily for 7 days. Week 2 (Days 8–14): Administer 10mg once daily for 7 days. Week 3 (Days 15–21): Administer 15mg once daily for 7 days. From Week 4 onward, administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. 2. Older adults Based on clinical data, the recommended dose for older patients aged 65 years and over is 20mg once daily. 3. Patients with renal impairment No dose adjustment is required in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance: 30-49 mL/min), the daily dose should be reduced to 10mg. If the medication is well tolerated after at least 7 days of treatment, the dose may be increased to 20mg once daily according to the standard dose-titration schedule. In patients with severe renal impairment (creatinine clearance: 5-29 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since no data are available on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medication.

Ingredients

Manufacturer
Eden Pharma Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

  • Alzheimer's disease
View approved original text

This medication is used to treat moderate to severe Alzheimer's disease. Alzheimer's disease is a condition characterized by memory decline and cognitive dysfunction, and this drug helps alleviate these symptoms and improve the daily functioning of patients.

How to take

Adult dose

Treatment must be initiated by a physician experienced in the diagnosis and treatment of Alzheimer’s dementia, and only if a caregiver can regularly check that the patient is taking the medication. The diagnosis should be made according to currently accepted guidelines. The clinical benefit of this medication and the patient’s tolerability of treatment should be regularly reassessed. This medication is administered orally once daily, at the same time each day. If necessary, it may be administered twice daily. It may be taken with or without food. 1. Adults Dose titration: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (Days 1–7): Administer 5mg once daily for 7 days. Week 2 (Days 8–14): Administer 10mg once daily for 7 days. Week 3 (Days 15–21): Administer 15mg once daily for 7 days. From Week 4 onward, administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. 2. Older adults Based on clinical data, the recommended dose for older patients aged 65 years and over is 20mg once daily. 3. Patients with renal impairment No dose adjustment is required in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance: 30-49 mL/min), the daily dose should be reduced to 10mg. If the medication is well tolerated after at least 7 days of treatment, the dose may be increased to 20mg once daily according to the standard dose-titration schedule. In patients with severe renal impairment (creatinine clearance: 5-29 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since no data are available on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medication.

Precautions

This medication should not be used in individuals who are allergic to any of its components. It should also not be administered to patients with very poor liver function or severely impaired kidney function. Caution should be exercised when used in patients with epilepsy or a history of seizures, especially if taken in conjunction with medications such as amantadine, ketamine, or dextromethorphan, as side effects may be exacerbated. Patients in situations where urine acidity (pH) may increase should be monitored carefully, and the safety of this drug has not been adequately confirmed in patients with recent myocardial infarction, heart failure, or uncontrolled hypertension. This drug may cause side effects such as dizziness, headache, constipation, drowsiness, and hypertension, and central nervous system abnormalities such as mental confusion, hallucinations, or seizures can occur rarely; if any abnormal symptoms appear, consult a physician immediately. This medication may interact with other drugs, so caution is required when taken with NMDA antagonists, antipsychotic drugs, muscle relaxants, anticoagulants, gastroprotective agents, etc., and all medications being taken should be disclosed to a physician or pharmacist. Pregnant women should consult a physician before taking this medication, and breastfeeding is not recommended while taking it. The safety and efficacy of this medication have not been established in children or adolescents under 18 years of age, and they should not be used in this population. Overdose may result in serious symptoms such as coma, confusion, hallucinations, or seizures, and in such cases, immediate medical attention is necessary. This medication may affect a patient's concentration and reaction time, so caution is especially necessary when driving or operating hazardous machinery. Finally, this medication should be stored out of the reach of children, and transferring it to other containers may affect the quality of the medication, so care should be taken.

Side effects

  • Dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity reaction
  • confusion
  • hallucinations
  • psychotic reactions
Show 24 more
  • balance disorders
  • gait abnormalities
  • seizures
  • heart failure
  • venous thrombosis/thromboembolism
  • respiratory distress
  • vomiting
  • pancreatitis
  • elevated liver function tests
  • hepatitis
  • fatigue
  • nonspecific fatigue
  • weakness
  • diarrhea
  • anxiety
  • aggression
  • stupor
  • unconsciousness
  • double vision
  • restlessness
  • psychosis
  • visual hallucinations
  • convulsions
  • coma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture ingress. It is best stored at room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Pink oval film-coated tablets

Package unit

Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.